# DIBBS #SPE2DP-27-T-0316

Supply of 28 bottles of moxifloxacin hydrochloride 400 mg tablets

**Posted:** November 13, 2026
**Respond By:** November 18, 2026
**Identifier:** SPE2DP-27-T-0316
**NAICS:** 424210

DLA Troop Support is seeking quotes for moxifloxacin hydrochloride tablets for its Medical Supply Chain Pharmaceutical FSA.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contact listed as Nicholas Quigley.
- **Product requested:** 28 bottles total of moxifloxacin hydrochloride 400 mg tablets, 30 tablets per bottle, NSN 6505-01-503-4772.
  - Five purchase requests: quantities of 8, 5, 5, 7, and 3 bottles.
- **Approved-source OEMs:** **Rising Pharma Holdings, Inc.** (NDC 57237-0156-30) and **Teva Pharmaceuticals USA, Inc.** (NDC 00093-7387-56).
- **Delivery and handling:** FOB destination, with delivery required within 20 days after award. Store at controlled room temperature and protect from high humidity.

### Description

MOXIFLOXACIN HYDROCHLO (QTY: 8, NSN: 6505-01-503-4772, Purchase Request: 7019117076)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROCHLO (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7019111850)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROCHLO (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7019119692)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROCHLO (QTY: 7, NSN: 6505-01-503-4772, Purchase Request: 7019092010)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROCHLO (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7019092019)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP27T0316)